The University of Notre Dame today announced that Dr. Anas Al-Janadi has been named as Harper Cancer Research Institute's first Associate Director for Clinical and Community Research and Chief of Oncology at Beacon Health System. This new position reflects the organizations' continued commitment to advancing cancer care across northern Indiana and southwest Michigan.
His appointment also represents an important step forward in Beacon's multi-year research collaboration agreement with the University. In this role at Beacon, Dr. Al-Janadi will lead the growth and transformation of oncology services across the health system. He will focus on strengthening multidisciplinary care, expanding access to services closer to home, advancing clinical outcomes and enhancing the patient experience. As he works to reshape the future of oncology services, Dr. Al-Janadi will bring together clinical excellence, research and innovation to better serve patients and families across the region.
“Dr. Al-Janadi stood out for his clinical vision, collaborative leadership and deep commitment to bringing research and innovation directly to patients,” said Mark Brett, Chief Operating Officer at Beacon Health System. “We are excited about what his arrival means for our teams, our oncology program, and the communities we serve.”
He will begin his new role on June 29. Dr. Al-Janadi most recently served as Chair of the Department of Cancer Care Services at Corewell Health. Since 2018, he built and advanced multidisciplinary oncology services across the health system by strengthening care delivery, aligning physicians and caregivers around shared goals and expanding access to high-quality cancer care. A board-certified hematologist and medical oncologist with more than 30 years of clinical experience, Dr. Al-Janadi is also an active researcher with published work across a range of oncology disciplines. His appointment followed a comprehensive national search.
Through his joint role with Notre Dame's Harper Cancer Research Institute, Dr. Al-Janadi will help bridge clinical care and scientific discovery, creating new opportunities to accelerate research, expand clinical trials and bring innovative treatment options to patients throughout our region.
This position was envisioned as part of Beacon and Notre Dame’s multi-year research collaboration, with a shared commitment to advancing oncology research and improving health outcomes in the communities served by our organizations.
“I am truly honored to join Beacon as Chief of Oncology, and I’m excited for the work ahead and proud to be part of the Beacon and Notre Dame communities,” Dr. Al-Janadi said. “My gratitude runs deep for the trust placed in me, for the mission-driven culture you've built, and for the opportunity to serve patients and families at such a pivotal moment in cancer care. I'm energized by the talent, compassion and innovation already thriving within these organizations. Together, I'm confident we will elevate our programs, expand access to leading-edge therapies and continue delivering the kind of care that changes lives.”
This story was originally published by Beacon Health System.
About Beacon Health System
Beacon Health System is a locally owned, nonprofit healthcare system serving patients across northern Indiana and southwest Michigan. Our nearly 11,000 associates and 2,500 medical staff providers, who are deeply rooted in our region, provide exceptional care with heartfelt compassion at Beacon Children's Hospital, Beacon Granger Hospital, Community Hospital of Bremen, Elkhart General Hospital, Memorial Epworth Center, Memorial Hospital of South Bend, Three Rivers Health, Beacon Kalamazoo, Beacon Allegan, Beacon Dowagiac and Beacon Plainwell. We are committed to serving underinsured and uninsured patients, furthering our commitment to community health and well-being. With our teams at Beacon Medical Group, Memorial Family Medicine Residency Program, Beacon Health Foundation and Beacon Health & Fitness, and through our partnership with Western Michigan University Homer Stryker M.D. School of Medicine, we are dedicated to delivering patient-centered care at every step of your health journey. Connect with us at BeaconHealthSystem.org.
About Harper Cancer Research Institute
Investigators in the Harper Cancer Research Institute (HCRI) are dedicated to conducting innovative and integrative research that confronts the complex challenges of cancer. Our programmatic structure fosters multi-disciplinary cancer research by promoting interactions among research groups with distinct expertise and by training early career scientists to work across scientific fields. Clinical partnerships provide key translational insight and strengthen the mission of discovery.
About Notre Dame Research
The University of Notre Dame is a private research and teaching university inspired by its Catholic mission. Located in South Bend, Indiana, its researchers are advancing human understanding through research, scholarship, education, and creative endeavor in order to be a repository for knowledge and a powerful means for doing good in the world. For more information, please visit NDR's website or NDR's LinkedIn.
Originally published by at research.nd.edu on June 17, 2026.